Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • granger
    Junior Member
    • Mar 2011
    • 7

    #1

    Nanostring nCounter: determining presence of target?

    The Nanostring Data analysis user manual describes options for determining presence or absence of target transcripts:
    a. Using the Background Threshold

    b. Statistical Tests
    1) Using a one-tailed, heteroscedastic t-test, calculate a p-value comparing the replicate gene counts to the background counts.
    2) Calculate the average of the replicate gene counts.
    3) If the average replicate gene counts are greater than the background threshold, and the p-value is less than your acceptable threshold confidence level, then the gene is detectable in the samples.
    However, I am questioning the validity of the second approach: the data are discrete numbers and also obviously present genes with high counts are returned as non-significant.

    I'm looking for any comment on this? What would be a good approach for calling expressed genes?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...